Anticonvulsant effect of exogenous β-hydroxybutyrate on kainic acid-induced epilepsy

Experimental and Therapeutic Medicine

Volumn 14, Issue 1, 2017, Pages 765-770

  Si, Jianping ^a,b   Wang, Shaohui ^c   Liu, Ning ^d   Yang, Xiaofei ^e   Wang, Ying ^f   Li, Ling ^d   Wang, Jiwen ^a   Lv, Xin ^d  

^a SHANDONG UNIVERSITY   (China)

^b Department of Pediatrics   (China)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

^d QILU CHILDREN S HOSPITAL OF SHANDONG UNIVERSITY   (China)

^e YIDU CENTRAL HOSPITAL OF WEIFANG   (China)

^f JINAN CENTRAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

Epilepsy; Kainic acid; Ketogenic diet; hydroxybutyrate

Indexed keywords

3 HYDROXYBUTYRIC ACID;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; BLOOD BIOCHEMISTRY; CELL LOSS; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; KAINIC ACID-INDUCED SEIZURE; MALE; NERVE CELL; NISSL STAINING; NONHUMAN; RAT;

EID: 85020509843     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2017.4552     Document Type: Article

References (22)

1. Banerjee PN, Filippi D and Hauser WA: The descriptive epidemiology of epilepsy-a review. Epilepsy Res 85: 31-45, 2009.
2. Luan G, Zhao Y, Zhai F, Chen Y and Li T: Ketogenic diet reduces Smac/Diablo and cytochrome c release and attenuates neuronal death in a mouse model of limbic epilepsy. Brain Res Bull 89: 79-85, 2012.
3. Kwan P and Brodie MJ: Early identification of refractory epilepsy. N Engl J Med 342: 314-319, 2000.
4. Wei C-X, Bian M and Gong GH: Current research on antiepileptic compounds. Molecules 20: 20741-20776, 2015.
5. Jiang Y, Yang Y, Wang S, Ding Y, Guo Y, Zhang MM, Wen SQ and Ding MP: Ketogenic diet protects against epileptogenesis as well as neuronal loss in amygdaloid-kindling seizures. Neurosci Lett 508: 22-26, 2012.
6. Suzuki Y, Takahashi H, Fukuda M, Hino H, Kobayashi K, Tanaka J and Ishii E: β-hydroxybutyrate alters GABA-transaminase activity in cultured astrocytes. Brain Res 1268: 17-23, 2009.
7. Gama IR, Trindade-Filho EM, Oliveira SL, Bueno NB, Melo IT, Cabral-Junior CR, Barros EM, Galvão JA, Pereira WS, Ferreira RC, et al: Effects of ketogenic diets on the occurrence of pilocarpine-induced status epilepticus of rats. Metab Brain Dis 30: 93-98, 2015.
8. van Delft R, Lambrechts D, Verschuure P, Hulsman J and Majoie M: Blood beta-hydroxybutyrate correlates better with seizure reduction due to ketogenic diet than do ketones in the urine. Seizure 19: 36-39, 2010.
9. Abdelmalik PA, Shannon P, Yiu A, Liang P, Adamchik Y, Weisspapir M, Samoilova M, Burnham WM and Carlen PL: Hypoglycemic seizures during transient hypoglycemia exacerbate hippocampal dysfunction. Neurobiol Dis 26: 646-660, 2007.
10. Yum MS, Ko TS and Kim DW: β-Hydroxybutyrate increases the pilocarpine-induced seizure threshold in young mice. Brain Dev 34: 181-184, 2012.
11. Minlebaev M and Khazipov R: Antiepileptic effects of endogenous beta-hydroxybutyrate in suckling infant rats. Epilepsy Res 95: 100-109, 2011.
12. Bough KJ, Chen RS and Eagles DA: Path analysis shows that increasing ketogenic ratio, but not β-hydroxybutyrate, elevates seizure threshold in the rat. Dev Neurosci 21: 400-406, 1999.
13. National Research Council: Guide for the Care and Use of Laboratory Animals. 8 edition. Washington (DC), National Academies Press (US), 103: pp 1072-1073, 2011.
14. Meidenbauer JJ and Roberts MF: Reduced glucose utilization underlies seizure protection with dietary therapy in epileptic EL mice. Epilepsy Behav 39: 48-54, 2014.
15. Löscher W: Current status and future directions in the pharmacotherapy of epilepsy. Trends Pharmacol Sci 23: 113-118, 2002.
16. Samoilova M, Weisspapir M, Abdelmalik P, Velumian AA and Carlen PL: Chronic in vitro ketosis is neuroprotective but not anti-convulsant. J Neurochem 113: 826-835, 2010.
17. Xie G, Tian W, Wei T and Liu F: The neuroprotective effects of β-hydroxybutyrate on Aβ-injected rat hippocampus in vivo and in Aβ-treated PC-12 cells in vitro. Free Radic Res 49: 139-150, 2015.
18. Neal EG, Chaffe H, Schwartz RH, Lawson MS, Edwards N, Fitzsimmons G, Whitney A and Cross JH: The ketogenic diet for the treatment of childhood epilepsy: A randomised controlled trial. Lancet Neurol 7: 500-506, 2008.
19. Henderson CB, Filloux FM, Alder SC, Lyon JL and Caplin DA: Efficacy of the ketogenic diet as a treatment option for epilepsy: Meta-analysis. J Child Neurol 21: 193-198, 2006.
20. Bough KJ and Eagles DA: A ketogenic diet increases the resistance to pentylenetetrazole-induced seizures in the rat. Epilepsia 40: 138-143, 1999.
21. Buckmaster PS, Zhang GF and Yamawaki R: Axon sprouting in a model of temporal lobe epilepsy creates a predominantly excitatory feedback circuit. J Neurosci 22: 6650-6658, 2002.
22. Giordano C, Marchiò M, Timofeeva E and Biagini G: Neuroactive peptides as putative mediators of antiepileptic ketogenic diets. Front Neurol 5: 63, 2014.